Watch

MIRMMirum Pharmaceuticals, Inc.

Healthcare · Biotechnology · mid-cap ($6.1B)
-25.3%
from rolling 252-day high of $130.00 set 2026-07-09 · 42d ago
Current
$97.18
Decline depth
-25.3%
Decline σ
4.4σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$MIRM landed on the list 2026-08-06, down 27.6% from its 52-week high that day — now down -25.3%.

It has clawed back 1.7 percentage points off that level.

Decline from the 52-week high as it stood on 2026-08-06 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

MIRM qualifies for the Watch on decline depth.

Decline depth
-25.3%
From rolling 252-day high of $130.00, 42d ago. Past the 20% Watch threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
4.4σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.83% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about MIRM.

MIRM qualifies for the Watch on decline depth — down -25.3% from its rolling 252-day high.

Cross-confirmation: also showing 3/5 bearish time frames.

Cross-confirmation: decline sigma also reads 4.4σ over 20 bars.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2U (red), monthly 2D (red).

Earnings on file: 2026-08-05. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about MIRM

What people ask.

Why is MIRM on Broken Stocks?

MIRM qualifies for the Watch on decline depth. It is down -25.3% from its rolling 252-day high of $130.00, set on 2026-07-09 — 42d ago.

Is MIRM a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. MIRM is down -25.3% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is MIRM a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is MIRM trading inside its 52-week range?

At $97.18, MIRM sits 50.8% of the way from its 52-week low ($63.23) to its 52-week high ($130.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has MIRM been declining?

The current 25.3% decline accrued over 42d, which annualizes to roughly -219.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does MIRM compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 70 Red, 35 Amber, 38 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — MIRM's decline is shallower than the sector median.

Does MIRM's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-08-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.